Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Disease and treatment characteristics of tuberculosis patients diagnosed through active case finding (ACF) and passive case finding (PCF), Nepal, 2018

From: The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal

Characteristics

ACF

n = 50

PCF

n = 49

All

n = 100

P-value a

Treatment status

n (%)

n (%)

n (%)

 

 New

42 (84)

40 (82)

82 (82)

0.755

 Retreatment/Relapse

8 (16)

9 (18)

17 (17)

HIV Status b

 Not tested

8 (16)

4 (8)

12 (12)

0.485

 Negative

39 (78)

40 (83)

79 (79)

 Unknown

3 (6)

4 (8)

7 (7)

Number of patients with reported hospitalization

 Pre-treatment

4 (8)

10 (20)

14 (14)

0.099

 Intensive phase

0

1 (2)

1 (1)

Total number of visits to health providers, pre-diagnosis c

N = 114

N = 133

N = 247

Type of service visited, pre-diagnosis

 TB camps

8 (7)

0

8 (3)

0.031

 Cross border service d

0

1 (1)

1 (0.5)

 Pharmacy/Herbalist

5 (4)

5 (4)

10 (4)

 Private clinic/hospital

42 (37)

55 (41)

97 (39)

 Public health facility

59 (52)

72 (54)

131 (53)

Total number of visits to health providers, intensive phase c

N = 61

N = 64

N = 125

Type of service visited, intensive phase

 No health facility

14 (23)

21 (33)

35 (28)

0.102

 Private clinic/hospital

7 (11)

13 (20)

20 (16)

 Public health facility

40 (66)

30 (47)

70 (56)

Average number of visits to health providers

Mean (SD)

Mean (SD)

Mean (SD)

 

 Health facility visits – pre-treatment

2.3 (1.1)

2.6 (1.6)

2.5 (1.4)

0.380

 Health facility visits – intensive phase

0.9 (0.9)

0.9 (0.9)c

0.9 (0.9)

0.500

 Follow-up visits - Intensive phase

0.2 (0.6)

0.4 (1.0)

0.3 (0.7)

0.026

Average number of days hospitalised

 Pre-treatment

5.3 (3.8)

8.1 (7.0)

7.5 (6.4)

0.638

Average number of weeks between 1st TB symptoms and treatment initiation

8.4 (8.0)

8.8 (11.3)

8.6 (9.8)

0.931

  1. a Two-sample Wilcoxon rank-sum (Mann-Whitney) test and Chi square
  2. b There is one missing data in HIV status
  3. c Patients can have more than one visit to different health facilities
  4. d Patient crossed the border to visit a health facility in India